Information:
Fel:
ID
34337
Beskrivning
Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2); ODM derived from: https://clinicaltrials.gov/show/NCT02509871
Länk
https://clinicaltrials.gov/show/NCT02509871
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hormonal Therapy NCT02509871
Eligibility Hormonal Therapy NCT02509871
- StudyEvent: Eligibility
Similar models
Eligibility Hormonal Therapy NCT02509871
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
postmenopausal women
boolean
ID.2
Item
patients requiring hormonal treatment
boolean
ID.3
Item
who performance status 0-2
boolean
ID.4
Item
patients initially included in metaca (au882) protocol
boolean
ID.5
Item
affiliation to a social security scheme (or be the beneficiary of such a plan)
boolean
ID.6
Item
patients who signed the informed consent form
boolean
ID.7
Item
patients witg relapse, with metastases or other cancer
boolean
ID.8
Item
concurrent treatment with a drug test, or participation in a clinical trial within < 30 days
boolean
ID.9
Item
patients carrying an electronic medical device (eg pacemaker)
boolean
ID.10
Item
patients who refused to sign the consent form
boolean